Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?
Saved in:
| Main Authors: | Claire E. Adams, Duncan G. Rutherford, Gareth R. Jones, Gwo-tzer Ho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Company of Biologists
2024-10-01
|
| Series: | Disease Models & Mechanisms |
| Online Access: | http://dmm.biologists.org/content/17/10/dmm050895 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
by: Yuming Lu, et al.
Published: (2025-01-01) -
Immunometabolism: signaling pathways, homeostasis, and therapeutic targets
by: Rongrong Xu, et al.
Published: (2024-11-01) -
Genetically engineered bacteria as inflammatory bowel disease therapeutics
by: Zhen-Ping Zou, et al.
Published: (2024-12-01) -
The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity
by: Yuwen Chen, et al.
Published: (2024-12-01) -
Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
by: Ronaldo Paolo Panganiban, et al.
Published: (2025-01-01)